strikhedonia

Yes. I would have been a lot happier with the Mustang moniker if they made it sedan shaped instead what we got.

You seem to be assuming that:

- I’m a tech worker

- I work from home

Neither of which are true. As an ‘essential’ worker, I found it deplorable how dismissive people are of our situation and display belligerence towards basic, near zero-cost safety measures, such as wearing a mask. Which, as the data suggest, was likely beneficial in allowing myself and many of my coworkers to avoid covid. Granted, we no longer wear masks, as they are no longer necessary.

I further find your argument regarding some nebulous, broad-scale wealth transfer unmoving. Personal incomes did well in my country for all income brackets during the pandemic. Doubtless, the situation served to funnel money large tech companies, but this seems an inevitable outcome regardless of government action.

In any case, you are clearly quite cemented in your position. Further discussion would be nonproductive.

You think asking people to wear a piece of cloth over their face and maybe not go out to eat if they’re vulnerable is “truly horrific?”

Seems to me that, for the vulnerable portion of the population, the social distancing guidelines worked perfectly. Spend a year chilling at home in safety, get a vaccine, go back to normal. “Rain dance?” Bullshit.

Your link doesn’t support your argument. California’s COL index will be dominated by the fact that it’s one of the nations most urban states, with two of the largest and wealthiest metro areas.

Indeed, my experience is that there are parts of CA that aren’t significantly more expensive than my Midwestern home state.

.. and significantly less than other logistics workers.

They’re paying a mean of $15 an hour. That’s quite different from a minimum of $15 an hour.

Walmart jobs in my fairly HCOL area still start at $12 an hour.

As pointed out by the preprint, the same effect is observed in serval other common vaccines (BCG, Measles, etc.)

Trial data for the mRNA vaccines has not yet indicated an elevated risk of experiencing a cytokine storm.

There’s really not much to get excited about here.

It’s actually one obvious death we’re aware of—the other five are still alive. Though that doesn’t change the calculus much.

We don’t have “long term data” for the next week or two, anyway. Phizer and Moderna’s chances of winning full use authorization this spring look quite good.